StockMarketWire.com - JP Morgan Cazenove today reaffirms its neutral investment rating on Circassia Pharmaceuticals Plc [LON:CIR] and cut its price target to 100p (from 125p).

Story provided by StockMarketWire.com

Broker Forecasts data provided by www.sharesmagazine.co.uk